Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 458 JPY 2.46% Market Closed
Market Cap: 35.4B JPY
Have any thoughts about
Fuji Pharma Co Ltd?
Write Note

Fuji Pharma Co Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Change in Working Capital
-ÂĄ6.9B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
-28%
Takeda Pharmaceutical Co Ltd
TSE:4502
Change in Working Capital
-ÂĄ346.6B
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
-15%
Daiichi Sankyo Co Ltd
TSE:4568
Change in Working Capital
ÂĄ217.2B
CAGR 3-Years
N/A
CAGR 5-Years
62%
CAGR 10-Years
26%
Otsuka Holdings Co Ltd
TSE:4578
Change in Working Capital
-ÂĄ128.2B
CAGR 3-Years
-77%
CAGR 5-Years
-80%
CAGR 10-Years
-1%
Chugai Pharmaceutical Co Ltd
TSE:4519
Change in Working Capital
-ÂĄ48.6B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Astellas Pharma Inc
TSE:4503
Change in Working Capital
-ÂĄ111.3B
CAGR 3-Years
N/A
CAGR 5-Years
-2%
CAGR 10-Years
-15%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
35.4B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 002.38 JPY
Undervaluation 27%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Change in Working Capital?
Change in Working Capital
-6.9B JPY

Based on the financial report for Jun 30, 2024, Fuji Pharma Co Ltd's Change in Working Capital amounts to -6.9B JPY.

What is Fuji Pharma Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-28%

Over the last year, the Change in Working Capital growth was -65%.

Back to Top